Myeloid-specific HNRNPA2B1 deficiency disrupts macrophage function and in vivo responses
The Journal of Immunology · 2025
DOI: 10.1093/jimmun/vkaf073 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Immunology, 2025. Verfasst von Mays Mohammed Salih und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular, Cell and Developmental Biology, University of California Santa Cruz, Santa Cruz, CA, United States. Hauptthemen laut MEDLINE: Macrophages, Heterogeneous-Nuclear Ribonucleoprotein Group A-B, Salmonella Infections, Myeloid Cells. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NIDDK NIH HHS, California Institute of Regenerative Medicine.
Abstract (Originalsprache)
The mechanisms through which heterogeneous nuclear ribonucleoprotein A2B1 (HNRNPA2B1) contributes to innate immune gene regulation are poorly understood. To fill this gap, we generated a myeloid lineage–specific HNRNPA2B1-conditional mouse using LysMCre. In an endotoxic shock model, HNRNPA2B1-deficient mice exhibit dampened expression of inflammatory mediators despite increased infiltration of macrophages and neutrophils. Likewise, during infection with the gram-negative bacterial pathogen Salmonella enterica, HNRNPA2B1-deficient mice fail to mount protective inflammatory responses and experience higher bacterial burdens. To better understand the molecular mechanisms driving these phenotypes in vivo, we performed transcriptomics analysis of LPS-treated HNRNPA2B1-deficient macrophages ex vivo. We noted an increase in transcripts encoding nonproductive isoforms of a number of Interferon (IFN)-regulated genes, including the IFNG receptor (IFNGR). Focusing on IFNGR, we confirmed lower surface expression on HNRNPA2B1-deficient macrophages and dampened responsiveness in response to IFNG treatment. In conclusion, our data demonstrates that HNRNPA2B1 is essential for optimal macrophage function, particularly in the context of intracellular bacterial restriction in the case of Salmonella infection. This highlights a previously unappreciated role for RNA-binding proteins in mounting effective immune defenses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular, Cell and Developmental Biology, University of California Santa Cruz, Santa Cruz, CA, United States.
- Department of Microbial Pathogenesis and Immunology, College of Medicine, Texas A&M University, Bryan, TX, United States.
- Department of Pathology, Microbiology, and Immunology, Vanderbilt University School of Medicine, Nashville, TN, United States.
ORCID-Profile: Susan Carpenter
Förderung
- NIGMS NIH HHS
- NIDDK NIH HHS
- California Institute of Regenerative Medicine
- California Institute of Regenerative Medicine/IBSC predoctoral training program
- NIAID NIH HHS
- NIAID
- NIGMS
Zitieren
APA
Salih, M. M., Weindel, C. G., Malekos, E., Sudek, L., Katzman, S., Mabry, C. J., Chapman, M. J., Coleman, A. K., Azam, S., Watson, R. O., Patrick, K. L., & Carpenter, S. (2025). Myeloid-specific HNRNPA2B1 deficiency disrupts macrophage function and in vivo responses. The Journal of Immunology. https://doi.org/10.1093/jimmun/vkaf073
Vancouver
Salih MM, Weindel CG, Malekos E, Sudek L, Katzman S, Mabry CJ, et al. Myeloid-specific HNRNPA2B1 deficiency disrupts macrophage function and in vivo responses. The Journal of Immunology. 2025. doi:10.1093/jimmun/vkaf073
BibTeX
@article{Salih2025,
author = {Salih, Mays Mohammed and Weindel, Chi G and Malekos, Eric and Sudek, Lisa and Katzman, Sol and Mabry, Cory J and Chapman, Morgan J and Coleman, Aja K and Azam, Sikandar and Watson, Robert O and Patrick, Kristin L and Carpenter, Susan},
title = {Myeloid-specific HNRNPA2B1 deficiency disrupts macrophage function and in vivo responses},
journal = {The Journal of Immunology},
year = {2025},
doi = {10.1093/jimmun/vkaf073}
}
EUVIMED